Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALK inhibitors
ALK inhibitors
Genentech’s Alecensa Reduces the Risk of Disease Recurrence or Death by an Unprecedented 76% in People With ALK-Positive Early-Stage Non-Small Cell Lung Cancer
BioSpace
Wed, 10/18/23 - 10:17 am
Genentech
Alecensa
ALK inhibitors
non-small cell lung cancer
ESMO
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Fierce Pharma
Mon, 06/5/17 - 12:08 pm
Takeda
Roche
ALK inhibitors
ASCO 2017
lung cancer
Novartis lung cancer drug gets EU recommendation
Yahoo/Reuters
Fri, 02/27/15 - 09:09 am
Novartis
Europe
Zykadia
ALK inhibitors
lung cancer